Klaas Schildknegt Selected Research

SAM-760

7/2018

Metabolism of a 5HT6 Antagonist, 2-Methyl-1-(Phenylsulfonyl)-4-(Piperazin-1-yl)-1H-Benzo[d]imidazole (SAM-760): Impact of Sulfonamide Metabolism on Diminution of a Ketoconazole-Mediated Clinical Drug-Drug Interaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Klaas Schildknegt Research Topics

Disease

2	Alzheimer Disease (Alzheimer's Disease) 07/2018 - 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Communicable Diseases (Infectious Diseases) 07/2016
1	Body Weight (Weight, Body) 06/2007
1	Obesity 06/2007

Drug/Important Bio-Agent (IBA)

1	SAM-760IBA 07/2018
1	imidazoleIBA 07/2018
1	ertugliflozinIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	SodiumIBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 07/2016
1	CP-809,101IBA 06/2007

Therapy/Procedure

1	Therapeutics 07/2016